be updated . please update this article to reflect recent events or newly available information . april 2014 c. r. bard inc. type public traded as nyse bcr s & p 500 component founded 1907 founder charles russell bard headquarters new providence new jersey u.s. area served worldwide key people timothy m. ring chairman & ceo products vascular urology oncology and surgical specialties revenue us 2.72 b fy 2010 1 operating income us 730m fy 2010 1 net income us 509m fy 2010 1 total assets us 3.17 b fy 2010 2 total equity us 1.63 b fy 2010 2 number of employees 14 000 2015 3 website www.crbard.com c. r. bard inc. now branded simply as bard headquartered in murray hill new jersey usa is a leading multinational developer manufacturer and marketer of medical technologies in the fields of vascular urology oncology and surgical specialties . bard markets its products and services worldwide to hospitals individual health care professionals extended care facilities and alternate site facilities . an s & p 500 company with approximately 14 000 employees in 2015 bard is perhaps best known for having introduced the foley catheter in 1934 . citation needed in 2013 bard began negotiations to settle nearly 30 000 legal claims related to implantable vaginal meshes made by the company . 4 contents 1 history 2 products 3 illegal kickback settlement 4 vaginal mesh device lawsuits 5 bard vena cava filter 6 references 7 external links history edit c. r. bard inc. was founded in new york city by charles r. bard in 1907 . bard s first business involved importing gomenol which was used to treat urinary discomfort . 5 the company formally incorporated in 1923 and three years later in 1926 charles r. bard sold the company to john f. willits and edson l. outwin for 18 000 . under willits and outwins the company expanded into the catheter business introducing the foley catheter in 1934 and the america woven catheter in 1940 . in 1948 bard s annual sales topped 1 million for the first time and the company moved its headquarters from new york city to summit new jersey . in 1954 a bard scientist dr. debakey developed the first arterial prosthesis . citation needed three years later the company began selling foley catheters that came in sterile packaging for the first time ever . bard continued to innovate in the world of catheters rolling out the bipolar temporary pacing catheter in 1958 and the first latex balloon catheter in 1960 . in 1961 bard expanded beyond catheters and began manufacturing products related to cardiology radiology and anesthesiology . bard went public in 1963 and was listed on the new york stock exchange in 1968 . the company has introduced a variety of new health care products since that time . its net sales first exceeded 1 billion in 1994 . around 2012 bard acquired the company lutonix . 6 products edit bard specializes in the manufacturing of vascular urology oncology and surgical specialty products . illegal kickback settlement edit in 2013 bard agreed to pay 48.26 million to resolve kickback allegations filed against the company relating to submitting false claims to medicare . the complaint filed in 2006 alleges bard paid illegal kickbacks to both physicians and consumers . 7 vaginal mesh device lawsuits edit vaginal mesh devices are threaded into the vagina to treat incontinence or to fortify pelvic muscles . some women have charged that the devices are poorly designed and contain materials that are unsafe for use in humans and that some require multiple surgeries to remove . 8 in 2012 the u.s. food and drug administration requested that bard and other vaginal mesh makers study rates of organ damage linked to the mesh devices . in 2013 bard began negotiations to settle nearly 30 000 legal claims related to implantable vaginal meshes made by the company . 4 in august 2015 it was announced that bard had agreed to pay more than 200 million to resolve at least 3 000 of the legal cases related to the devices . the settlement resolves about one fifth of the outstanding suits related to the implants . bard said in court filings its devices are safe and effective . 8 bard vena cava filter edit an inferior vena cava filter or more simply a blood clot filter is a device that is surgically placed in the vena cava artery to prevent blood clots from moving into the heart or lungs which can be fatal . on december 31 2015 nbc news released information about an investigation that they had conducted of the bard g2 series filters which had replaced an earlier version the recovery filter . introduced in 2002 the recovery filter was associated with 27 deaths and several hundred non fatal problems and a confidential study commissioned by bard showed that the recovery filter had higher rates of relative risk for death filter fracture and movement than all of its competitors . however according to the nbc report the g2 series filters were a modified version of the recovery filter and bard was aware that it had similar and potentially fatal flaws shortly after it was put on the market . but instead of recalling the replacement filters they were kept on the market for five years . according to bard and fda records at least 12 deaths and hundreds of problems have been linked to the g2 series filters . 9 references edit a b c c.r. bard bcr annual sec income statement filing via wikinvest . a b c.r. bard bcr annual sec balance sheet filing via wikinvest . cr bard at yahoo finance a b c.r. bard negotiating to settle thousands of lawsuits involving vaginal mesh implants . nj.com . retrieved 15 april 2014 . anthony hallett diane hallett entrepreneur magazine encyclopedia of entrepreneurs page 27 1997 charles r. bard ... during a trip to europe he encountered a medicine called gomenol derived from the eucalyptus tree which relieved his ... george john september 5 2012 intact vascular raises 15.5 m developing stapler to replace stents philadelphia business journal bizjournals.com retrieved september 5 2012 tycko jonathan . top whistleblower settlements of 2013 to date . the national law review . retrieved 6 november 2013 . a b feely jef 4 august 2015 . bard said to pay 200 million to settle vaginal mesh cases . bloomberg . retrieved 1 january 2016 . sandler tim ; gosk stephanie 31 december 2015 . why did firm keep selling problem blood clot filters . nbc news . retrieved 1 january 2016 . external links edit official website profile on linkedin profile on youtube profile on facebook retrieved from https en.wikipedia.org w index.php title c. r. bard & oldid 744328559 categories companies established in 1907companies listed on the new york stock exchangebiotechnology companies of the united statescompanies based in union county new jerseynew providence new jerseyhidden categories wikipedia articles in need of updating from april 2014all wikipedia articles in need of updatingpages using infobox company with unsupported parametersall articles with unsourced statementsarticles with unsourced statements from april 2014 navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages fran ais edit links this page was last modified on 14 october 2016 at 14 31 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view